Back to Clinical Trials Overview

Your search for "Heart" returned 62 results:

LVAD Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function
Principal Investigator(s): Deborah Ascheim, MD

A Clinical Evaluation of the Medtronic Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm
Principal Investigator(s): Kim, Michael

Cardiothoracic Surgical Trials Network
Principal Investigator(s): Gelijns, Annetine

Endothelial Function in Fibromuscular Dysplasia
Principal Investigator(s): Olin, Jeffrey W.

A Prospective Randomized Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS element) for the Treatment of up to Two De Novo Coronary Artery Lesions - PLATINUM Trial
Principal Investigator(s): Kini, Annapoorna

Coronary Computer Tomography for Systemic Triage:CT-STAT
Principal Investigator(s): Garcia, Mario J.

Advanced Glycation End Products (AGEs) and Alzheimer’s Disease
Principal Investigator(s): Schnaider-Beeri, Michal

Defining the optimal dose of caudal-Epidural Morphine in Pediatric Cardiac Surgery
Principal Investigator(s): Hollinger, Ingrid

Can The LiDCO System Assess Potential Volume Responsiveness In The Open Chest Condition?
Principal Investigator(s): Stone, Marc

Multicenter, randomized, 12 week, double-blind, placebo-controlled, parallel-group, Phase IIA study using F-fluorodeoxyglucose (FDG)-PET to measure the effects of rilapladib on in-vivo macrophage activity in subjects with established atherosclerosis
Principal Investigator(s): Farkouh, Michael E.

The Vest Prevention of Early Sudden Death Trial (VEST) PREDiction of ICD Therapies (PREDICTS)
Principal Investigator(s): Skipitaris, Nicholas

The Cardiac Benefit of Androgen Replacement in Hypogonadal Males with Coronary Artery Disease Following Successful Percutaneous Coronary Intervention (PCI)
Principal Investigator(s): McLaughlin, Mary A

Haptoglobin Genotype and Diabetes Mellitus in the Development of Atherosclerosis
Principal Investigator(s): Moreno, Pedro

Observational Study of Alloimmunity in Cardiac Trans Pts
Principal Investigator(s): Pinney, Sean

Chronometric Observations of Lipid Core Containing Plaques of Interest in Native Coronary Arteries Registry (COLOR Registry)
Principal Investigator(s): Kim, Michael

Surgical Ablation vs No Surgical Ablation for Patients with Persistent or Longstanding Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery
Principal Investigator(s): Gelijns, Annetine

Novel Imaging to Predict Cardiovascular Events in Diabetes
Principal Investigator(s): Farkouh, Michael E.

Principal Investigator(s): Sharma, Samin

A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety And Effectiveness of the Tryton Side Branch Stent™ used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation (TRYTON side-branch stent TRIAL)
Principal Investigator(s): Samin Sharma, MD

Surgical Interventions for Moderate Ischemic Mitral Regurgitation
Principal Investigator(s): Ascheim, Deborah

A non-randomized, single-blinded, open-label, investigator-initiated, pre-marketing, single-center, crossed-over Phase III clinical trial of the 12-Lead ECG Glove (12-LEG) for the assessment of cardiac electrical function. (EKG Glove Study)
Principal Investigator(s): Annapoorna Kini, MD

Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy (YELLOW Trial)
Principal Investigator(s): Annapoorna Kini, MD

Continued Access PROTECT AF Registry: CAP Registry
Principal Investigator(s): Reddy, Vivek

Early extubation in children after congenital heart surgery
Principal Investigator(s): Mittnacht, Alexander

Effect of Particulate Matter Exposure on Carotid Plaque Neovascularization Using Dynamic Contrast Enhances Magnetic Resonance Imaging
Principal Investigator(s): McLaughlin, Mary A

DAL Outcomes: A phase III double blind, randomized placebo-controlled study, to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in stable CHD patients
Principal Investigator(s): Smith, Donald A MDMPH

A Prospective, Two-Arm, Open-Label, Multi-Center Registry using XIENCE PRIME EECSS and XIENCE PRIME LL EECSS (SPIRIT-PRIME)
Principal Investigator(s): Sharma, Samin

JOSTENT Coronary Stent Graft
Principal Investigator(s): Sharma, Samin

Patient Management Guided w/ Cerebral Oximetty in Cardiac
Principal Investigator(s): Fischer, Gregory W

Tolvaptan on Hemodynamic Parameters in Pts. w/ Heart Failure
Principal Investigator(s): Pinney, Sean

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
Principal Investigator(s): Sharma, Samin

Management Practices and the Risk of Infection Following Cardiac Surgery
Principal Investigator(s): Gelijns, Annetine

Genetic Determinants of Pheripheral arterial disease
Principal Investigator(s): Olin, Jeffrey W.

Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation
Principal Investigator(s): Moskowitz, Alan

Evaluation of the Safety and Effectiveness of the OPTIMIZER System in Subjects With Heart Failure (FIX-HF)
Principal Investigator(s): Kalman, Jill

Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2DM)
Principal Investigator(s): Robert Rosenson, MD

A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease
Principal Investigator(s): Farkouh, Michael E.

The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Principal Investigator(s): Ascheim, Deborah

Effect of VIA-2291 on Vascular Inflammation after ACS
Principal Investigator(s): Farkouh, Michael E.

Model 4396 Left Ventricular Lead Clinical Study
Principal Investigator(s): Mehta, Davendra

Investigation of delirium in postoperative cardiac surgical patients in the ICU
Principal Investigator(s): Flynn, Brigid

24 Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Two Exposures of Concentration-Controlled Certican With Reduced Neoral Versus 3.0g MMF With Standard Dose Neoral In De Novo Heart Transplant Recipients
Principal Investigator(s): Pinney, Sean

Genetic Markers Associated with Statin-Induced Myalgia and myopathy
Principal Investigator(s): Smith, Donald A MDMPH

A Randomized, Open Label, Investigator-Initiated Trial comparing Intravascular Ultrasound-Guided Atherectomy to Angiography-Guided Atherectomy in Peripheral Vascular Interventions for TASC's A, B, C lesions. (UTOPIA trial)
Principal Investigator(s): Prakash Krishnan

Ambulatory Closure Device Percutaneous Intervention
Principal Investigator(s): Kim, Michael

A Prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI [Protect II]
Principal Investigator(s): Sharma, Samin

Hormones, Sexual Well-Being & Cardiac Outcomes/Diabetics
Principal Investigator(s): McLaughlin, Mary A

Beta Blocker Therapy vs. Angiotensin II in Marfan
Principal Investigator(s): Gelb, Bruce D M.D.

WTC CHEST (Pulmonary Abnormalities, Diastolic Dysfunction, and World Trade Center Exposure: Implications for Diagnosis and Treatment)
Principal Investigator(s): Mary Ann McLaughlin, MD MPH

American Legacy Smoking Cessation Study
Principal Investigator(s): Claudia I. Henschke

Coronary Assessment by Near infrared of Atherosclerotic Rupture-prone Yellow [CANARY Trial]
Principal Investigator(s): Annapoorna Kini, MD

Warfarin vs. Aspirin in Reduced Cardiac Ejection Fraction (WARCEF)
Principal Investigator(s): Darrow, Bruce

Modified stepwise Ablation Guided by low dose Ibutilide in Chronic Atrial Fibrillation Trial (MAGIC-AF)
Principal Investigator(s): Vivek Reddy

CObalt chromium STent with Antiproliferation for Restenosis II Trial
Principal Investigator(s): Samin K. Sharma, MD

CARES:A Prospective, Phase IV, Open-Label, Non-Randomiozed, Multicenter, Surveillance REgistry Study to Evaluate the Safety of DEFINITY in Clinical Practice
Principal Investigator(s): Goldman, Martin

Early Extubation Pediatric Cardiac Anesthesia Study (Retrospective)
Principal Investigator(s): Mittnacht, Alexander

Effects of High Dose Statin Therapy (FDG)/Atheroscleroti
Principal Investigator(s): Farkouh, Michael E.

A Phase 1/2 Trial of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects with Heart Failure Divided into Two Stages: Stage One Open-Label, Sequential Dose-Escalation Cohorts and Stage Two Randomized, Double-Blind, Placebo-Control, Parallel Cohorts (CUPID)
Principal Investigator(s): Kalman, Jill

Near Infrared Spectroscopy in Children Undergoing Congenital Heart Surgery
Principal Investigator(s): Mittnacht, Alexander

Clinical Evaluation of Remote Notification (CONNECT)
Principal Investigator(s): Fischer, Avi

COPES Phase I Randomized Controlled Trial of Treatment For Distress in Heart Disease Patients
Principal Investigator(s): Davidson, Karina

Future Revascularization Evaluation in Patients with Diabetes Mellitus:Optimal Management of Multivessel Disease (FREEDOM Trial)
Principal Investigator(s): Sharma, Samin